On the recordJuly 19, 2011
I think a lot of the problem is that either the FDA does not have the resources or there are problems at FDA in processing what is going on or there are problems with the developers.
Source
congress.govI think a lot of the problem is that either the FDA does not have the resources or there are problems at FDA in processing what is going on or there are problems with the developers.
Waxman discusses issues with FDA resources and device approval processes.
Share
More from Henry Waxman
The use of performance enhancing substance was pervasive for more than a decade, and that everyone in baseball -- the players, the union, the owners and the commissioner -- were responsible.
It is not for the President to say or to obstruct congressional deliberations and investigations or other legitimate functions.
The Federal Government would maintain its commitment to sharing the costs of providing basic healthcare and long-term coverage to vulnerable Americans.